Improving chronic care delivery and outcomes: The impact of the cystic fibrosis Care Center Network

BMJ Quality and Safety

Volumn 23, Issue SUPPL1, 2014, Pages

  Mogayzel Jr , Peter J ^a   Dunitz, Jordan ^b   Marrow, Laura C ^c   Hazle, Leslie A ^c,d  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c CYSTIC FIBROSIS FOUNDATION   (United States)

^d SPECTRUM HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; CLINICAL RESEARCH; CYSTIC FIBROSIS; FAMILY RELATION; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HUMAN; LEADERSHIP; LUNG FUNCTION; MEDICAL EDUCATION; MEDICAL SPECIALIST; OUTCOME ASSESSMENT; PATIENT CARE; PHYSICIAN; QUALITY OF LIFE; SURVIVAL; CHRONIC DISEASE; COMMUNITY CARE; FEMALE; HEALTH CARE QUALITY; HOSPITAL; LONG TERM CARE; MALE; MORTALITY; ORGANIZATION; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; UNITED STATES;

CHRONIC DISEASE; COMMUNITY NETWORKS; CYSTIC FIBROSIS; DELIVERY OF HEALTH CARE; FEMALE; HOSPITALS, CHRONIC DISEASE; HUMANS; LONG-TERM CARE; MALE; ORGANIZATIONAL INNOVATION; OUTPATIENT CLINICS, HOSPITAL; PATIENT CARE; PATIENT CARE TEAM; QUALITY ASSURANCE, HEALTH CARE; UNITED STATES;

EID: 84896534827     PISSN: 20445415     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmjqs-2013-002363     Document Type: Article

References (24)

1. Cystic Fibrosis Patient Registry. Cystic Fibrosis Foundation, Bethesda, Maryland, 2012.
2. O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009;373:1891-904.
3. Mogayzel PJ Jr, Naureckas ET, Robinson KA, et al. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2013;187:680-9.
4. Moran A, Becker D, Casella SJ, et al. Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: A technical review. Diabetes Care 2010;33:2677-83.
5. Moran A, Dunitz J, Nathan B, et al. Cystic fibrosis-related diabetes: Current trends in prevalence, incidence, and mortality. Diabetes Care 2009;32:1626-31.
6. Sanders DB, Bittner RC, Rosenfeld M, et al. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol 2011;46:393-400.
7. Konstan MW, Morgan WJ, Butler SM, et al. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr 2007;151:134-9, 39 e1.
8. Corey M, Edwards L, Levison H, et al. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr 1997;131:809-14.
9. Rosenfeld M, Davis R, Fitz Simmons S, et al. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997;145:794-803.
10. Schechter MS, Shelton BJ, Margolis PA, et al. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med 2001;163:1331-7.
11. Emerson J, Rosenfeld M, McNamara S, et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002;34:91-100.
12. Kosorok MR, Zeng L, West SE, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001;32:277-87.
13. Schaedel C, De Monestrol I, Hjelte L, et al. Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol 2002;33:483-91.
14. Dasenbrook EC, Checkley W, Merlo CA, et al. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA 2010;303:2386-92.
15. Dasenbrook EC, Merlo CA, Diener-West M, et al. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med 2008;178:814-21.
16. Lewin LO, Byard PJ, Davis PB. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol 1990;43:125-31.
17. Courtney JM, Dunbar KE, McDowell A, et al. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults. J Cyst Fibros 2004;3:93-8.
18. Yen EH, Quinton H, Borowitz D. Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis. J Pediatr 2013;162:530-35.
19. Zemel BS, Jawad AF, Fitz Simmons S, et al. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: Analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr 2000;137:374-80.
20. Eakin MN, Bilderback A, Boyle MP, et al. Longitudinal association between medication adherence and lung health in people with cystic fibrosis. J Cyst Fibros 2011;10:258-64.
21. Collaco JM, Vanscoy L, Bremer L, et al. Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA 2008;299:417-24.
22. O'Connor GT, Quinton HB, Kneeland T, et al. Median household income and mortality rate in cystic fibrosis. Pediatrics 2003;111(4 Pt 1):e333-9.
23. http://www.cff.org/treatments/cfcareguidelines
24. Schechter M, Fink A, Homa K, et al. The Cystic Fibrosis Foundation Patient Registry as a Tool for Use in Quality Improvement. BMJ Qual Saf 2014;23:i9-14.